Stavroula Tsitkanou Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Post Doctoral Research Fellow

University of Arkansas at Fayetteville

postdoc

9 h-index 27 pubs 469 cited

Research Areas

Muscle Physiology and Disorders Cancer-related molecular mechanisms research Mitochondrial Function and Pathology Neuroscience and Neural Engineering MicroRNA in disease regulation Diet and metabolism studies Physical Activity and Health

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Stavroula Tsitkanou's research investigates the physiological changes associated with cancer cachexia and other conditions affecting muscle health. Her work has explored how muscle weakness can precede observable atrophy in cancer cachexia and how exercise may counteract these effects. Tsitkanou has also examined sex-based differences in muscle response to cachexia and hindlimb unloading, noting preserved muscle quality in females compared to males during early stages of cachexia. Her publications also address the potential of mitochondrial-targeted therapies, such as SkQ1, to mitigate muscle wasting and improve contractility in tumor-bearing mice. Additionally, her research extends to the role of microRNAs in neurodegenerative conditions, specifically investigating how miR-23a suppression affects functional decline in a mouse model of TDP-43 proteinopathy.

Metrics

h-index: 9
Publications: 27
Citations: 469

Selected Publications

Promoting mitochondrial fusion is protective against cancer-induced muscle detriments in males and females (2025) DOI
Mitochondrial-targeted plastoquinone therapy prevents early onset muscle weakness that occurs before atrophy during ovarian cancer (2025) DOI
Global mitophagy inhibition via BNIP3 ablation is not sufficient to alleviate skeletal muscle impairments in male and female tumor-bearing mice (2025) DOI
Myocellular adaptations to short‐term weighted wheel‐running exercise are largely conserved during C26‐tumour induction in male and female mice (2025) DOI
Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in mice (2024) DOI
Mitochondrial antioxidant SkQ1 attenuates C26 cancer-induced muscle wasting in males and improves muscle contractility in female tumor-bearing mice (2024) DOI
Exercise training induces mild skeletal muscle adaptations without altering disease progression in a TDP-43 mouse model (2024) DOI
Biological sex divergence in transcriptomic profiles during the onset of hindlimb unloading-induced atrophy (2023) DOI
Females display relatively preserved muscle quality compared with males during the onset and early stages of C26-induced cancer cachexia (2023) DOI
Mitochondria-Targeted Antioxidant SkQ1 Improves Muscle Contractility in Female C26 Tumor-Bearing Mice (2023) DOI
Vastus Lateralis and Vastus Intermedius as Predictors of Quadriceps Femoris Muscle Hypertrophy after Strength Training (2022) DOI
Exercise Counteracts the Deleterious Effects of Cancer Cachexia (2022) DOI